Introduction to ASCO 2025 Lung Cancer Immunotherapy Updates At the MOASC/ANCO Immuno-Oncology Symposium held on September 6, 2025, in Marina del Rey, Dr. Navid Hafez, MD, MPH, delivered a compelling overview of ASCO 2025’s most impactful lung cancer immunotherapy data. Drawing from the symposium’s focus on advancing cancer care in California, Dr. Hafez highlighted transformative … Continue reading ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium